We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,137 results
  1. Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours

    Background

    Type II testicular germ cell tumours (TGCT) are the most prevalent tumours in young men. Patients suffering from cisplatin-resistant TGCTs...

    Kai Funke, Ulf Einsfelder, ... Hubert Schorle in British Journal of Cancer
    Article Open access 06 April 2023
  2. Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium

    Germ cell tumours (GCTs) are a heterogeneous group of rare neoplasms that present in different anatomical sites and across a wide spectrum of patient...

    Adriana Fonseca, João Lobo, ... Matthew J. Murray in British Journal of Cancer
    Article Open access 13 October 2022
  3. Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling

    Background

    Testicular germ cell tumours (TGCTs) are the most commonly diagnosed malignancy in young men. Although cisplatin has been shown to be...

    Kancheng He, Zitaiyu Li, ... Yuxin Tang in Cancer Cell International
    Article Open access 09 March 2022
  4. Predicted leukocyte telomere length and risk of germ cell tumours

    Background

    Genetically predicted leukocyte telomere length (LTL) has been evaluated in several studies of childhood and adult cancer. We test whether...

    Shannon S. Cigan, John J. Meredith, ... Jenny N. Poynter in British Journal of Cancer
    Article 02 April 2022
  5. Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption

    Background

    MiR-371~373 and miR-302/367 cluster over-expression occurs in all malignant germ cell tumours (GCTs), regardless of age (paediatric/adult),...

    Shivani Bailey, Marta Ferraresso, ... Matthew J. Murray in British Journal of Cancer
    Article Open access 03 October 2023
  6. Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours

    Background

    Testicular germ cell tumours (TGCTs) have a high metastasis rate. However, the mechanisms related to their invasion, progression and...

    Tim Nestler, Priya Dalvi, ... Axel Heidenreich in British Journal of Cancer
    Article Open access 12 January 2022
  7. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours

    Background

    MiR-371a-3p predicts the presence of a macroscopic non-teratomatous germ cell tumour (GCT). We hypothesised that miR-371a-3p can also...

    Christian D. Fankhauser, Ailsa J. Christiansen, ... Thomas Hermanns in British Journal of Cancer
    Article 15 December 2021
  8. Combination treatment of zinc and selenium intervention ameliorated BPA-exposed germ cell damage in SD rats: elucidation of molecular mechanisms

    Bisphenol A (BPA) is a commonly used environmental toxicant, is easily exposed to the human body and causes testicular damage, sperm abnormalities,...

    Chittaranjan Sahu, Gopabandhu Jena in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 18 March 2024
  9. Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders

    Background

    Both testicular germ cell tumours (TGCT) and neurodevelopmental disorders are associated with urogenital malformations. Few studies have...

    Anna K. Jansson, Jonas Söderling, ... Ingrid Glimelius in British Journal of Cancer
    Article Open access 24 April 2023
  10. RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma

    Background

    Testicular germ cell tumours (TGCTs) have a high sensitivity to chemotherapy and a high cure rate, although with serious adverse effects....

    Christine Hjorth Andreassen, Mette Lorenzen, ... Martin Blomberg Jensen in British Journal of Cancer
    Article 13 April 2022
  11. Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours

    Background

    Testicular germ cell tumours (TGCTs) are characterised by an overall high cisplatin-sensitivity which has been linked to their continued...

    K. Harpelunde Poulsen, J. E. Nielsen, ... A. Jørgensen in BMC Cancer
    Article Open access 23 April 2020
  12. Whole-genome methylation analysis of testicular germ cells from cryptozoospermic men points to recurrent and functionally relevant DNA methylation changes

    Background

    Several studies have reported an association between male infertility and aberrant sperm DNA methylation patterns, in particular in...

    Sara Di Persio, Elsa Leitão, ... Bernhard Horsthemke in Clinical Epigenetics
    Article Open access 21 August 2021
  13. Impact of a one-year supervised physical activity program on long-term cancer-related fatigue and mediating effects of the gut microbiota in metastatic testicular cancer patients: protocol of the prospective multicentre, randomized controlled phase-III STARTER trial

    Background

    Testicular germ cell tumours (TGCTs) are the most common malignancy in men aged 15–40 years, with increasing incidence worldwide. About...

    Hwayoung Noh, Amélie Anota, ... Olivia Pérol in BMC Cancer
    Article Open access 15 January 2024
  14. The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)

    Background

    The germ cell supranetwork multidisciplinary team (SMDT) for the Anglian Network covers a population of 7.5 million.

    Methods ...
    Jonathan Shamash, Wendy Ansell, ... Anju Sahdev in British Journal of Cancer
    Article Open access 29 September 2020
  15. Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database

    Background

    Active surveillance after orchiectomy is the preferred management in clinical stage I (CSI) germ-cell tumours (GCT) associated with a 15 to...

    Jakob Lauritsen, Nicolas Sauvé, ... Gedske Daugaard in British Journal of Cancer
    Article Open access 30 September 2023
  16. Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors

    Background

    Non-seminoma testicular cancer survivors (TCS) have an increased risk of develo** colorectal cancer (CRC) when they have been treated...

    Berbel L. M. Ykema, Emilie C. H. Breekveldt, ... Monique E. van Leerdam in British Journal of Cancer
    Article 10 September 2022
  17. Human germ cell tumours from a developmental perspective

    Human germ cell tumours (GCTs) are derived from stem cells of the early embryo and the germ line. They occur in the gonads (ovaries and testes) and...

    J. Wolter Oosterhuis, Leendert H. J. Looijenga in Nature Reviews Cancer
    Article 14 August 2019
  18. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours

    Background

    Germ cell tumours (GCTs) represent a highly curable malignity as they respond well to cisplatin (CDDP)-based chemotherapy. Nevertheless, a...

    Zuzana Cierna, Vera Miskovska, ... Miroslav Chovanec in BMC Cancer
    Article Open access 06 January 2020
  19. CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms

    Background

    Germ cell tumours (GCTs) are the most common solid malignancies in young men. Although high cure rates can be achieved, metastases,...

    Margaretha A. Skowron, Marieke Vermeulen, ... Daniel Nettersheim in British Journal of Cancer
    Article Open access 18 May 2020
  20. A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours

    Background

    To explore the expression and carcinogenic mechanism of RIPK2 in human tumours, and to provide the theoretical basis for the further study...

    Hanqun Zhang, Yan Ma, ... **aohu Wang in BMC Medical Genomics
    Article Open access 26 April 2022
Did you find what you were looking for? Share feedback.